Baryta carbonica (Granules) Instructions for Use
Marketing Authorization Holder
Boiron (France)
Contact Information
BOIRON (France)
ATC Code
V30 (Not assigned)
Dosage Forms
| Baryta carbonica | Homeopathic granules C5: 4 g tube with granule counter | |
| Homeopathic granules C9: 4 g tube with granule counter | ||
| Homeopathic granules C15: 4 g tube with granule counter | ||
| Homeopathic granules C30: 4 g tube with granule counter |
Dosage Form, Packaging, and Product Composition
| Homeopathic granules | Potency |
| Baryta carbonica (Baryta carbonica) | C5 |
| Homeopathic granules | Potency |
| Baryta carbonica (Baryta carbonica) | C9 |
| Homeopathic granules | Potency |
| Baryta carbonica (Baryta carbonica) | C15 |
| Homeopathic granules | Potency |
| Baryta carbonica (Baryta carbonica) | C30 |
Excipients : sucrose, lactose.
4 g – tubes with granule counter (1) – cardboard packs.
Clinical-Pharmacological Group
Single-component homeopathic preparation of mineral-chemical origin
Pharmacotherapeutic Group
Homeopathic agent
Pharmacological Action
Barium carbonate is used in measured doses in conventional medicine drugs.
It has a hypotensive effect on arterial circulation caused by vascular atherosclerosis.
It acts on sclerotic degeneration of connective tissue.
Indications
Key symptoms for prescribing the drug
- Mental, nervous, and physical weakness;
- Chronic hypertrophy of the tonsils with frequent inflammation;
- Tendency to suppuration of ENT organs, causing difficulty swallowing and accompanied by bulky submandibular and cervical lymphadenopathy;
- Delayed psychomotor development;
- Delayed puberty.
Main cases of clinical application
Otorhinolaryngology
- Hypertrophied tonsils, prevention of recurrent tonsillitis.
Behavioral disorders
- Delayed physical and especially mental development; problems with learning school subjects.
Disorders related to aging
- Hypertension caused by arteriosclerosis (in addition to prescribed allopathic treatment);
- Prevention of pathological aging;
- Pulmonary sclerosis (pneumosclerosis) and chronic bronchitis in the elderly;
- Motor and intellectual consequences of strokes;
- Prostate adenoma.
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Sublingually.
The granules should be dissolved in the mouth 30 minutes before a meal or 60 minutes after a meal.
For children from 0 to 3 years old, the granules are first diluted by shaking in 10-15 ml of water at room temperature and given to drink 30 minutes before a meal or 60 minutes after a meal.
The optimal amount per dose is 5 granules.
Consultation with a doctor is necessary to determine the potency, frequency, and duration of administration.
Adverse Reactions
None described to date.
Contraindications
- Individual sensitivity to the drug;
- Lactose intolerance.
Special Precautions
The dosage regimen and frequency of administration are determined by the doctor.
If there is no therapeutic effect within 3 days, or if adverse reactions occur, you should consult a doctor.
Overdose
No information on overdose cases has been received to date.
Drug Interactions
It is possible to use other medicines while being treated with Baryta carbonica.
Storage Conditions
At a temperature not exceeding 25°C (77°F).
Shelf Life
Shelf life is 5 years.
Dispensing Status
The drug is available without a prescription.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer